Press Releases

This phase I/II clinical trial on Type I Diabetics seeks to compare the performance of this Combo based on insulin Glargine with HumalogMix(R). Adocia , a biotechnology company specializing in the development of ‘best-in-class’ medicines...

Avedro Inc. a Boston-based ophthalmic medical device and pharmaceutical company announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking. Lasik with cross-linking...

Oxford Optronix, the leading provider of advanced research instrumentation for the clinical medicine and life science industries, today announces the formal launch of HypoxyLab™ – the industry’s first benchtop, HEPA-filtered, precision-controlled hypoxia workstation. HypoxyLab creates...

Promethera Biosciences has conducted the trial in Belgium, France, United Kingdom, Italy and Israel, treating twenty patients affected by very rare liver-based metabolic diseases. Promethera Biosciences, a Belgian biotechnology company developing Promethera(R) HepaStem, a cell-based...

Neuroptis Biotech, the ophthalmology drug research and development specialist, announces positive results in preclinical trials of the eye-drop formulation of its ML7 product. ML7 is intended for use in the treatment of eye surface diseases, particularly dry eye.  ...

Covance Inc. , one of the world's largest and most comprehensive drug development companies, and PathoQuest, a pioneer in the field of pathogen detection, today announce an exclusive agreement to collaborate in providing Next-Generation Sequencing (NGS) based biosafety assessments. ...

Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, has completed its efficacy study of olesoxime in the rare neurodegenerative condition Spinal Muscular Atrophy...